Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Oct 18;120(16):3187-205.
doi: 10.1182/blood-2012-03-362608. Epub 2012 Aug 9.

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

Ursula Creutzig  1 , Marry M van den Heuvel-Eibrink, Brenda Gibson, Michael N Dworzak, Souichi Adachi, Eveline de Bont, Jochen Harbott, Henrik Hasle, Donna Johnston, Akitoshi Kinoshita, Thomas Lehrnbecher, Guy Leverger, Ester Mejstrikova, Soheil Meshinchi, Andrea Pession, Susana C Raimondi, Lillian Sung, Jan Stary, Christian M Zwaan, Gertjan J L Kaspers, Dirk Reinhardt; AML Committee of the International BFM Study Group
Affiliations
Free article
Review

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

Ursula Creutzig et al. Blood. .
Free article

Abstract

Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML) remains a life-threatening malignancy in children, with current survival rates of ∼70%. State-of-the-art recommendations in adult AML have recently been published in this journal by Döhner et al. The primary goal of an international expert panel of the International BFM Study Group AML Committee was to set standards for the management, diagnosis, response assessment, and treatment in childhood AML. This paper aims to discuss differences between childhood and adult AML, and to highlight recommendations that are specific to children. The particular relevance of new diagnostic and prognostic molecular markers in pediatric AML is presented. The general management of pediatric AML, the management of specific pediatric AML cohorts (such as infants) or subtypes of the disease occurring in children (such as Down syndrome related AML), as well as new therapeutic approaches, and the role of supportive care are discussed.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles
-